Showing results (2841-2850 of 6,780) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|April 20, 2010
Monoclonal antibodies in the treatment of metastatic colorectal cancer: a reviewJolien Tol, Cornelis J A PuntClinical Therapeutics|April 20, 2010
Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort studyToni L Ripley, Donald Harrison, Robin E Germany, et al.Clinical Therapeutics|April 20, 2010
Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapyTakaaki Suzuki, Masahiro Takeuchi, Hiromi Saeki, et al.Clinical Therapeutics|April 20, 2010
Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteersMuzaffar Iqbal, Arshad Khuroo, Lakhvinder S Batolar, et al.Clinical Therapeutics|October 8, 2009
Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and childrenDevada Singh-Franco, Hoytin Lee Ghin, Gisela I Robles, et al.Clinical Therapeutics|October 8, 2009
Neutralization of alpha(2)-antiplasmin by microplasmin: a randomized, double-blind, placebo-controlled, ascending-dose study in healthy male volunteersSteve Pakola, Geraldine Cahillane, Jean-Marie Stassen, et al.Clinical Therapeutics|October 8, 2009
Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trialMesut OgrendikClinical Therapeutics|October 8, 2009
Pattern and predictors of the initiation of biologic agents for the treatment of rheumatoid arthritis in the United States: an analysis using a large observational data bankEsi Morgan DeWitt, Li Lin, Henry A Glick, et al.Clinical Therapeutics|May 4, 2010
Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trialRoeland Huijgen, Evertine J Abbink, Eric Bruckert, et al.Clinical Therapeutics|May 4, 2010
Changes in the QTc interval after administration of flecainide acetate, with and without coadministered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjectsKyoung Soo Lim, In-Jin Jang, Bo-Hyung Kim, et al.Pageof 678